Showing results (2251-2260 of 9,332) with videos related to
Sort By:
Pageof 934
Cancer Medicine|July 13, 2026
HK2/VDAC1 Axis Regulates Malignant Progression of Esophageal Squamous Cell CarcinomaChenlu Dai, Jingyu Liu, Yaling Guan, et al.Cancer Medicine|July 10, 2026
Efficacy and Safety of rhIL-11 in the Treatment of Cancer Therapy-Induced Thrombocytopenia: A Multicenter Retrospective StudyYingmei Wen, Yi Dong, Yingge Li, et al.Cancer Medicine|March 24, 2026
Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical SignificanceXin Yan, Xiaoyu Tang, Linfa Guo, et al.Cancer Medicine|March 25, 2026
Qualitative Study of Breast Cancer and Lymphoma Patients Participating in a Physical Activity Intervention: The Case for Tailored Physical ActivityBrianna N Leitzelar, Juliana V Costa, Aylin A Aguilar, et al.Cancer Medicine|March 19, 2026
A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL StudyWang Xicheng, Deng Yanhong, Zhang Yanqiao, et al.Cancer Medicine|March 20, 2026
JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK-STAT Signaling PathwayXiuyan Wang, Sha Luan, Lei Sun, et al.Cancer Medicine|March 27, 2026
Initial Site of Metastasis Influences Prognosis in Pancreatic Ductal AdenocarcinomaEleanor Mancheski, David Baek, Wilbur Bowne, et al.Cancer Medicine|March 27, 2026
Enhancing Quality of Life in Head and Neck Cancer: A Scoping Review on the Role of Physical PrehabilitationAlice Maria Santagostino, Mauro Parozzi, Giovanni Cangelosi, et al.Cancer Medicine|April 20, 2026
Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric CohortJesús Yaringaño, Oriol Mirallas, Víctor Navarro, et al.Cancer Medicine|March 23, 2026
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant ImmunotherapyPablo Llerena, Praneet C Kaki, Kathryn Nunes, et al.Pageof 934